Trieza Therapeutics has named Jeno Gyuris its chief scientific officer. Cambridge, MA-based Trieza is developing cancer immunotherapies that use viruses to prompt an anti-tumor response. Gyuris’ experience includes senior scientific posts at two other Boston-area biotechs, Aveo Pharmaceuticals (NASDAQ: [[ticker:AVEO]]) and Quiet Therapeutics.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
